The effect of autoimmune blistering diseases on work productivity

被引:10
作者
Wang, E. Q. [1 ,2 ,3 ]
Radjenovic, M. [1 ,2 ]
Castrillon, M. A. [2 ,3 ,4 ]
Feng, G. H. Y. [5 ]
Murrell, D. F. [1 ,2 ,3 ,6 ]
机构
[1] St George Hosp, Dept Dermatol, Sydney, NSW, Australia
[2] Premier Specialists Res & Dev, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, Randwick, NSW, Australia
[4] Univ Desarrollo, Clin Alemana, Fac Med, Clin Alemana Santiago, Santiago, Chile
[5] Univ Sydney, Fac Math & Stat, Sydney, NSW, Australia
[6] Univ Sydney, Fac Med, Sydney, NSW, Australia
关键词
QUALITY-OF-LIFE; ACTIVITY IMPAIRMENT; SEVERE PSORIASIS; BULLOUS DERMATOSES; PEMPHIGUS; MODERATE; QUESTIONNAIRE; VALIDATION; DERMATITIS; INSTRUMENT;
D O I
10.1111/jdv.15062
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background Autoimmune blistering diseases (AIBD) are known to negatively impact upon quality of life (QoL); however, there is a paucity of research on the effect of AIBD on work productivity. AIBD can be quite disfiguring in terms of a patient's appearance due to their blistering nature. ObjectiveMethodsTo determine the impact of AIBD on work productivity and to determine whether patients are stigmatized at work due to their appearance. Sixty-one patients with AIBD completed the Work Productivity and Activity Impairment Questionnaire-Specific Health Problem (WPAIQ-SHP), the Dermatology Life Quality Index (DLQI), the Autoimmune Bullous Disease Quality of Life (ABQOL) and the Treatment of Autoimmune Bullous Disease Quality of Life questionnaires (TABQOL). ResultsConclusionNon-responders to treatment had more work and activity impairment compared to responders. Worse WPAIQ-SHP scores were correlated with higher ABQOL, TABQOL and DLQI scores. Approximately 14.8% of subjects experienced stigmatization at work due to their appearance. The most common body areas stigmatized were easily visible sites, particularly the hands, arms and feet, with the majority of occurrences related to co-workers; for some patients, this stigmatization occurred on a daily basis. Loss of productivity at work was statistically much higher in those with higher disease severity, ABQOL & TABQOL scores and in non-responders to treatment. Autoimmune blistering diseases negatively impacts upon work productivity and activity. Stigmatization was common in the workplace which leads to increased stress, itself a stimulator of pemphigus.
引用
收藏
页码:1959 / 1966
页数:8
相关论文
共 24 条
  • [1] The Dermatology Life Quality Index 1994-2007: a comprehensive review of validation data and clinical results
    Basra, M. K. A.
    Fenech, R.
    Gatt, R. M.
    Salek, M. S.
    Finlay, A. Y.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2008, 159 (05) : 997 - 1035
  • [2] Work-Related Lost Productivity and Its Economic Impact on Canadian Patients with Moderate to Severe Psoriasis
    Chan, Brian
    Hales, Brigette
    Shear, Neil
    Ho, Vincent
    Lynde, Charles
    Poulin, Yves
    Mittmann, Nicole
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2009, 13 (04) : 192 - 197
  • [3] Pemphigus and Quality of Life
    Chee, Shien-Ning
    Murrell, Dedee F.
    [J]. DERMATOLOGIC CLINICS, 2011, 29 (03) : 521 - +
  • [4] Severity score indexes for blistering diseases
    Daniel, Benjamin S.
    Hertl, Michael
    Werth, Victoria P.
    Eming, Ruediger
    Murrell, Dedee F.
    [J]. CLINICS IN DERMATOLOGY, 2012, 30 (01) : 108 - 113
  • [5] Loss of Work Productivity and Quality of Life in Patients With Autoimmune Bullous Dermatoses
    Heelan, K.
    Hitzig, S. L.
    Knowles, S.
    Drucker, A. M.
    Mittmann, N.
    Walsh, S.
    Shear, N. H.
    [J]. JOURNAL OF CUTANEOUS MEDICINE AND SURGERY, 2015, 19 (06) : 546 - 554
  • [6] Patterns of remission in pemphigus vulgaris
    Herbst, A
    Bystryn, JC
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2000, 42 (03) : 422 - 427
  • [7] Underdiagnosis and undertreatment of cardiovascular risk factors in patients with moderate to severe psoriasis
    Kimball, Alexa B.
    Szapary, Philippe
    Mrowietz, Ulrich
    Reich, Kristian
    Langley, Richard G.
    You, Yin
    Hsu, Ming-Chun
    Yeilding, Newman
    Rader, Daniel J.
    Mehta, Nehal N.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (01) : 76 - 85
  • [8] Efficacy and Safety of Adalimumab among Patients with Moderate to Severe Psoriasis with Co-Morbidities Subanalysis of Results from a Randomized, Double-Blind, Placebo-Controlled, Phase III Trial
    Kimball, Alexa B.
    Bensimon, Arielle G.
    Guerin, Annie
    Yu, Andrew P.
    Wu, Eric Q.
    Okun, Martin M.
    Bao, Yanjun
    Gupta, Shiraz R.
    Mulani, Parvez M.
    [J]. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY, 2011, 12 (01) : 51 - 62
  • [9] Korman NJ, 2015, DERMATOL ONLINE J, V21, P16
  • [10] Quality of life, depression, anxiety and loneliness in patients with bullous pemphigoid. A case control study
    Kouris, Anargyros
    Platsidaki, Eftychia
    Christodoulou, Christos
    Armyra, Kalliopi
    Korkoliakou, Panagiota
    Stefanaki, Christina
    Tsatovidou, Revekka
    Rigopoulos, Dimitrios
    Kontochristopoulos, George
    [J]. ANAIS BRASILEIROS DE DERMATOLOGIA, 2016, 91 (05) : 601 - 603